[ad_1]
The government has released a tentative list of recommended priority groups that will receive the coronavirus vaccine first, Liverpool Echo reports.
Although an effective vaccine to combat the killer virus has not yet been developed, once an effective one has been found, there will undoubtedly be a massive demand.
The Joint Committee on Vaccination and Immunization issued an independent report that included discussions on the rollout of any safe and effective vaccine, as soon as it was licensed for use in the UK.
The committee that advises UK health departments on immunization looked at who should get priority for any vaccine.
Liverpool Echo reports that the advisory group was strongly in favor of a simple age-based program that would likely result in faster delivery and better uptake in those most at risk.
This tentative priority list is subject to change, but is based on vaccines in development and tentative timelines for vaccine availability.
PA reports that the JCVI added that any vaccination program must also ensure good coverage among Black, Asian and Ethnic Minority Communities (BAME), as well as among people living in disadvantaged areas.
Groups with underlying conditions that could lead to priority vaccination include people who have suffered a stroke, people with poorly controlled diabetes, chronic lung disease, obesity (BMI over 40), or liver disease.
Jon Cohen, Emeritus Professor of Infectious Diseases at Brighton and Sussex School of Medicine, said: “Posting an initial discussion on how a Covid vaccine would be implemented is an important and welcome first step.”
He said the “sensitive question” will be whether the first available vaccine “offers only limited protection and, as is certainly possible, is only weakly effective in older people.”
“As the JCVI says, this can significantly alter the ranking of priorities,” he added.
He said future data would depend on the outcome of global vaccine trials.
According to the report, the provisional priority ranking for people at risk is as follows:
- elderly resident in a nursing home and nursing home workers
- all those aged 80 or over and health and social assistance workers
- all those 75 years and up
- all those 70 years and more
- all those 65 and over
- high-risk adults under 65
- moderate-risk adults younger than 65
- all those 60 years and more
- all those 55 and over
- all those 50 years and more
-
rest of the population (priority to be determined)
This list could change substantially depending on whether the vaccine is less effective or inappropriate for older adults.
The race to develop a vaccine to end the global pandemic has meant that there are now more than 170 candidate vaccines that the World Health Organization (WHO) tracks.
Vaccines generally require more than two years of testing before they are ready for use. However, earlier this week, Health Secretary Matt Hancock said a “massive launch” of a vaccine could be seen early next year.
Currently, the UK has access to six different Covid-19 vaccine candidates in development.
Professor Robin Shattock, who leads Imperial College London’s Covid-19 vaccination effort, told the European Parliament on Tuesday that the use of a coronavirus could be approved by the middle of next year.
He said the trials are showing promising results and that human volunteers appear to be “responding well” to the vaccine.
[ad_2]